Corporacio Parc Tauli
Sabadell, Barcelona, 08208, Spain
NCT Number: NCT00863135
The purpose of this study is to determine the effects of CPAP treatment on blood pressure in patients with sleep apnea syndrome (SAS) and refractory arterial hypertension (RAH).
Also, some of the mechanisms mediating SAS and RAH (systemic inflammation, oxidative stress, sympathetic hyperactivity) will be analyzed.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Sabadell, Barcelona, 08208, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
continuous positive airways pressure
Patients are 3 months without any change in their treatment, and are in the waiting list to come into the CPAP procedure after that time
Time frame: basal and after three months of CPAP treatment
Time frame: basal and after three months of CPAP treatment
Corporacion Parc Tauli
Other
Effect of Continuous Positive Airway Pressure (CPAP) Treatment on Blood Pressure in Patients With Sleep Apnea and Refractory Hypertension
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06785454
Apnea, Cardiovascular Diseases
Tuscaloosa, Alabama, United States
View Trial DetailsNCT00777985
Apnea, Cardiovascular Diseases
Grenoble, France
View Trial DetailsNCT05077748
Apnea, Cardiovascular Complication
Hong Kong, China
View Trial DetailsNCT06690723
Apnea, Cardiovascular Diseases
Sarawak, Malaysia
View Trial Details